472 related articles for article (PubMed ID: 32951569)
1. Indole Derivatives as Anti-Tubercular Agents: An Overview on their Synthesis and Biological Activities.
Reddy GS; Pal M
Curr Med Chem; 2021; 28(22):4531-4568. PubMed ID: 32951569
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
Soares A; Estevao MS; Marques MMB; Kovalishyn V; Latino DARS; Aires-de-Sousa J; Ramos J; Viveiros M; Martins F
Med Chem; 2017; 13(5):439-447. PubMed ID: 28185538
[TBL] [Abstract][Full Text] [Related]
5. Indole: A promising scaffold for the discovery and development of potential anti-tubercular agents.
Bajad NG; Singh SK; Singh SK; Singh TD; Singh M
Curr Res Pharmacol Drug Discov; 2022; 3():100119. PubMed ID: 35992375
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone derivatives and their anti-tubercular activities.
Fan YL; Wu JB; Cheng XW; Zhang FZ; Feng LS
Eur J Med Chem; 2018 Feb; 146():554-563. PubMed ID: 29407980
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in
Negatu DA; Yamada Y; Xi Y; Go ML; Zimmerman M; Ganapathy U; Dartois V; Gengenbacher M; Dick T
mBio; 2019 Mar; 10(2):. PubMed ID: 30914514
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
9. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
[TBL] [Abstract][Full Text] [Related]
11. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
12. Isoniazid derivatives and their anti-tubercular activity.
Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
[TBL] [Abstract][Full Text] [Related]
13. Recent advances of pyrazole-containing derivatives as anti-tubercular agents.
Xu Z; Gao C; Ren QC; Song XF; Feng LS; Lv ZS
Eur J Med Chem; 2017 Oct; 139():429-440. PubMed ID: 28818767
[TBL] [Abstract][Full Text] [Related]
14. Promising Antimycobacterial Activities of Flavonoids against
Rabaan AA; Alhumaid S; Albayat H; Alsaeed M; Alofi FS; Al-Howaidi MH; Turkistani SA; Alhajri SM; Alahmed HE; Alzahrani AB; Mashraqi MM; Alwarthan S; Alhajri M; Alshahrani FS; Almuthree SA; Alsubki RA; Abuzaid AA; Alfaresi M; Al Fares MA; Mutair AA
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014572
[TBL] [Abstract][Full Text] [Related]
15. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
[TBL] [Abstract][Full Text] [Related]
16. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
Yadav RR; Khan SI; Singh S; Khan IA; Vishwakarma RA; Bharate SB
Eur J Med Chem; 2015 Jun; 98():160-9. PubMed ID: 26005918
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
Reddyrajula R; Etikyala U; Manga V; Kumar Dalimba U
Bioorg Med Chem; 2024 Jan; 98():117562. PubMed ID: 38184947
[TBL] [Abstract][Full Text] [Related]
19. Neoteric advancement in TB drugs and an overview on the anti-tubercular role of peptides through computational approaches.
Khusro A; Aarti C; Barbabosa-Pliego A; Salem AZM
Microb Pathog; 2018 Jan; 114():80-89. PubMed ID: 29174699
[TBL] [Abstract][Full Text] [Related]
20. Isoniazid Derivatives as Anti-Tubercular Agents: From Structural Design to Clinical Investigations.
Ridahunlang N; Bisht R; Rishanlang N
Infect Disord Drug Targets; 2023; 23(3):e041022209552. PubMed ID: 36200205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
